These figures from the 2020 report...
16.INTANGIBLES
Patents and trademarks
At cost 2,683,554
Accumulated amortisation(926,552)
Balance of value 1,757,002
Upfront payment to CDY = $500,000 (AUD or USD??)
Discount to Provelmare = ~72% !!
As for the 4% royalty...how much, over how many years, has CDY netted from the operations of PEB??
See how "Mr Market" assesses "IMMEDIATE VALUE"!!!!
And here is another admission of ??? from the Board in today's announcement ... “We are delighted to hand over this exciting drug development program to its new owner, Provelmare Holdings..."
To reiterate Bottsy's remark yesterday..."I'm also speechless".
Ann: Agreement Signed for Sale of Lyramid Limited, page-12
-
- There are more pages in this discussion • 322 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1197315 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 109888 | 2 |
View Market Depth
| Last trade - 16.12pm 16/08/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable